Latest Growth factors Stories
Neulasta Delivery Kit Provides Administration Option for Patients who may not Otherwise Need to Return to Clinic or Hospital the day After Chemotherapy THOUSAND OAKS, Calif., March
Company currently has two biosimilar applications (filgrastim [Neupogen(®)]) and pegfilgrastim [Neulasta(®)]) under active review by FDA. TORONTO, Feb.
PORTLAND, Oregon, January 15, 2015 /PRNewswire/ -- A new report by Allied Market Research titled, "Global Erythropoietin (EPO) Drugs Market (Type, Application and Geography)
LAKE FOREST, Ill., Jan.
RARITAN, N.J. and SAN ANTONIO, Dec.
ResearchMoz.us include new market research report " China Recombinant Protein Drug Industry, 2014-2017: Market Size, Shares, Growth, Analysis, Trends And Forecast" to its huge collection
Surveyed European Oncologists Expect to Use Future Biosimilar G-CSFs in a Greater Proportion of Eligible Patients than Biosimilar MAbs, According to Findings from Decision Resources Group BURLINGTON,
RnRMarketResearch.com adds "Hematopoietic Stem Cell Transplantation – Pipeline Review, H2 2014" to its store.
CYRAMZA now approved both as a single-agent treatment and in combination with chemotherapy INDIANAPOLIS, Nov.
Nutronics Labs remains the only Deer Antler Spray manufacturer to have studies conducted on their own products RENO, Nev., Oct.
- In medieval musical notation, a sign or neume denoting a shake or trill.